Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “POOR PROGNOSIS”

180 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 180 results

Testing effectiveness (Phase 2)Study completedNCT00204633
What this trial is testing

Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)

Who this might be right for
Dysgerminoma
University Hospital Tuebingen 108
Testing effectiveness (Phase 2)Study completedNCT00002931
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
City of Hope Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT00195104
What this trial is testing

Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML

Who this might be right for
Myelodysplastic Syndrome
Weill Medical College of Cornell University 87
Post-approval studies (Phase 4)Study completedNCT04446845
What this trial is testing

Double Stimulation Followed by a Fresh Embryo Transfer

Who this might be right for
Infertility
Fundación Santiago Dexeus Font 120
Not applicableStudy completedNCT00963703
What this trial is testing

Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University of Manitoba 15
Testing effectiveness (Phase 2)Study completedNCT00003402
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
University of Maryland, Baltimore 35
Not applicableStudy completedNCT06887439
What this trial is testing

Association of EASIX in Sepsis

Who this might be right for
SepsisSeptic ShockSeptic Syndrome
Sisli Hamidiye Etfal Training and Research Hospital 150
Not applicableLooking for participantsNCT06477042
What this trial is testing

Act on Quality of Life in Patients With aortIc Stenosis

Who this might be right for
Severe Aortic Stenosis
Hospices Civils de Lyon 240
Not applicableStudy completedNCT02226692
What this trial is testing

Prognostic Factors of Disabling Low Back Pain in Patients With Chronic Low Back Pain

Who this might be right for
Chronic Low Back PainMechanical Low Back Pain
Université du Québec à Trois-Rivières 53
Testing effectiveness (Phase 2)Study completedNCT00141765
What this trial is testing

Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

Who this might be right for
Wilms TumorFibrosarcomaCarcinoma, Round Cell+2 more
University of Michigan Rogel Cancer Center 25
Post-approval studies (Phase 4)Study completedNCT03846544
What this trial is testing

Double Pick up in Poor Prognosis Women

Who this might be right for
Fertility Disorders
CRG UZ Brussel 48
Testing effectiveness (Phase 2)Study completedNCT00189137
What this trial is testing

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
University of Michigan Rogel Cancer Center 84
Testing effectiveness (Phase 2)Study completedNCT00002509
What this trial is testing

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer

Who this might be right for
Breast Cancer
Temple University
Testing effectiveness (Phase 2)Ended earlyNCT02089230
What this trial is testing

MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 19
Not applicableEnded earlyNCT00900068
What this trial is testing

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 9
Not applicableNot Yet RecruitingNCT06958224
What this trial is testing

Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers

Who this might be right for
Breast CancerLiver CancerPancreatic Ductal Adenocarcinoma
University Hospital, Lille 360
Not applicableStudy completedNCT01482507
What this trial is testing

Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Optimus Clinical Research 10
Early research (Phase 1)Study completedNCT00278330
What this trial is testing

Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+4 more
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Testing effectiveness (Phase 2)Ended earlyNCT00074269
What this trial is testing

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Diego 5
Load More Results